U.S. Pharmacist eNewsletter
March 2023

Transcranial Magnetic Stimulation for Medication-Resistant MDD
Recent findings indicated that repetitive transcranial magnetic stimulation (rTMS) effectively treated medication-resistant major depression. The researchers examined prospective data from adult patients with major depressive disorder (MDD) who received rTMS at five university hospitals in France. This is the largest study to evaluate the efficacy of rTMS on the dorsolateral prefrontal cortex in patients with treatment-resistant depression in real-world practice.
Read more.


Familial History and Higher Risk of Major Depression
In a study published in the Journal of the American Medical Association Psychiatry, researchers conducted a Danish cohort study to explore the correlations between familial major depression (MD) history and risk of MD, including correlation with age, gender, type of kinship, and age of the affected family member. Learn more about the results of this study.

Long-Term Air Pollution Exposure and Risk of Depression, Anxiety
According to a recent study, long-term exposure to multiple air pollutants—even at low concentrations—increases the risk of depression and anxiety. Previous research indicated that air pollution is now recognized as an important environmental risk factor for developing mental health issues; however, epidemiologic evidence on long-term exposure to low levels of air pollutants with incident depression and anxiety is still minimal. Read more.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App